At Mikajaki, we are pioneering the development of a multi-ocular AI-driven robotic platform designed for automated examination and diagnosis in ophthalmology.
Our innovative suite of products offers a comprehensive solution for end-to-end ophthalmological diagnosis. It begins with our Ariane suite, a virtual agent that collects subjective patient information to enhance diagnostic accuracy and predict ocular aberrations. This is complemented by our Eyelib robotic platform, which safely, swiftly, and consistently gathers objective optical measurements of patients’ eyes.
Following data collection, our novel AI-driven diagnostics integrate both objective and subjective information to identify predicted abnormalities, assess risks, determine refraction, and recommend the most appropriate patient-specific surgeries. Additionally, our platform calculates parameters such as IOL power for cataract treatment, providing a rational basis for timely interventions. To support healthcare providers, we have developed the SmartVision report, an integrated tool that reviews collected data and predictions, presenting clear, comprehensive, and relevant information to facilitate diagnosis.
Our suite of solutions, Eyelib + Ariane, delivers:
1. Affordable eye care and diagnostic solutions in areas with limited access to such services.
2. A portable device, reducing the need for expensive clinic space and enabling deployment almost anywhere.
3. An easy-to-operate platform that requires minimal technical training, thus conserving on expensive workforce.
4. A repeatable measurement system with consistent conditions, offering a significant advantage in data analysis and interpretation.
5. Reduction of human bias in the analysis of results.
6. An adaptable, flexible, and trainable platform that can adjust to clinic-specific diagnostic practices.
Overall, Mikajaki’s integrated approach revolutionizes ophthalmological diagnostics, enhancing accuracy, efficiency, and accessibility in eye care.